SCHEMBL25853508

SCHEMBL25853508

CCCc1cc(Cl)cc(C(C)CO)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
CNR2 P34972 2/20 0.33
ABCB11 O95342 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
CNR1 P21554 1/20 0.32
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
NR3C1 P04150 1/20 0.30
PGR P06401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17071834 0.80 ABCB11 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16770774 0.80 ABCB11 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16952371 0.80 CNR2 (0.31) CNR2KDM4EALDH1A1POLBGAA
SCHEMBL25857978 0.77 ABCB11 (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7634231 0.76 TSHR (0.44) CNR2KDM4EALDH1A1POLBGAA
SCHEMBL28599339 0.76 CNR2 (0.39) CNR2KDM4EALDH1A1POLBGAA
SCHEMBL16952302 0.75 CNR2 (0.37) CNR2KDM4EALDH1A1POLBGAA
SCHEMBL18893300 0.74 ALDH1A1 (0.37) ALDH1A1GAAGABRA1GABRB1NR3C1
SCHEMBL10130853 0.73 LPL (0.45) CNR2ABCB11CNR1
SCHEMBL25857242 0.73 ABCB11 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023135233-A1 AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS AGV DISCOVERY (FR) 2023-07-20 WO disclosed